Semaglutide, known by brand names like Wegovy, is an FDA-approved GLP-1 receptor agonist
Additionally, there was a strong linear association between the length of the intervention (weeks) and changes in HbA1C, as well as a significant nonlinear link between the dosage (2 g/day) and changes in insulin
The patients who do this well tend to plan protein the way diabetic patients plan carbs: with awareness, with some loose tracking, with a small rotation of meals they know hit the target
Phase 2 data noted increases in heart rate with retatrutide, consistent with observations across the incretin class
Kramer and Bressan, 2019)
If a patient is constantly nauseated, unable to eat properly, or feeling unwell, the medication may no longer be the right tool